Bubble CPAP is associated with a decreased risk for chronic lung disease and decreased use of sedatives in preterm neonates, results of a new quality improvement project.

Bubble CPAP is associated with a decreased risk for chronic lung disease and decreased use of sedatives in preterm neonates, results of a new quality improvement project.

This report examined the effectiveness of adopting bubble CPAP management strategy to reduce respiratory complications and medication usage in a community hospital NICU. Authors assessed the efficacy of bubble CPAP by comparing 45 neonates who were managed with bubble CPAP to 87 neonates (historical control) who were managed by conventional ventilation.

Authors report that after the introduction of the bubble CPAP, the number of days on mechanical ventilation and days on supplemental oxygen decreased in the bubble CPAP group compared with the conventional ventilation group. CLD was reduced from 30% pre-implementation to 4% post-implementation. In addition, there was a significant decrease in the use of sedative medications in the bubble CPAP group. Read more

Miller et al: Decreasing Chronic Lung Disease Associated with Bubble CPAP Technology: Experience at Five Years, Pediatric Quality and Safety: March/April 2020 – Volume 5 – Issue 2 – p e281.

Start exploring our learning modules in bCPAP.

The Bubble CPAP Institute is an interactive educational platform aiming to make the knowledge and skill set of Bubble CPAP accessible to practitioners who care for neonates and young infants across the globe. This platform will primarily focus on the know-how and will offer educational modules on issues like when to consider bCPAP in managing infants with respiratory distress, how to assemble the bCPAP circuits, how to apply the nasal interface and how to troubleshoot bedside issues.

Read modules